Fortitude Family Office’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$424K Sell
1,172
-6
-0.5% -$2.05K 0.08% 99
2026
Q1
$414K Sell
1,178
-1,429
-55% -$509K 0.09% 97
2025
Q4
$853K Buy
2,607
+27
+1% +$8.56K 0.2% 80
2025
Q3
$728K Buy
2,580
+1
+0% +$290 0.2% 80
2025
Q2
$720K Sell
2,579
-25
-1% -$7.08K 0.24% 67
2025
Q1
$811K Sell
2,604
-64
-2% -$18.9K 0.29% 46
2024
Q4
$695K Buy
2,668
+24
+0.9% +$7.12K 0.25% 61
2024
Q3
$852K Buy
2,644
+697
+36% +$228K 0.34% 43
2024
Q2
$608K Buy
1,947
+306
+19% +$89.9K 0.35% 44
2024
Q1
$467K Hold
1,641
0.31% 47
2023
Q4
$473K Buy
+1,641
New +$447K 0.35% 46

Other funds holding AMGN

Fortitude Family Office's AMGN Position: Q2 2026 in Review

Fortitude Family Office reduced its Amgen (AMGN) stake by 0.51% in Q2 2026, selling an estimated $2.05K and leaving 1,172 shares worth $424K. The position accounts for 0.08% of the portfolio, ranked #99.

Fortitude Family Office first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $853K in Q4 2025. 1,465 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Fortitude Family Office held 1,172 shares of Amgen worth $424K as of Q2 2026.
  • Fortitude Family Office sold 6 Amgen shares in Q2 2026, an estimated $2.05K.
  • Amgen made up 0.08% of Fortitude Family Office's portfolio in Q2 2026, its #99 holding.
  • Fortitude Family Office first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • Fortitude Family Office's Amgen position peaked at $853K in Q4 2025.
  • 1,465 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.